Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Published

Psilocybin: a psychedelic alternative to antidepressants?

In November 2022, the largest trial to date of the psychedelic drug, psilocybin, showed that - alongside psychological support - a single 25mg dose could improve the symptoms of treatment-resistant depression for up to 12 weeks. Previous studies have suggested an antidepressant mechanism for psilocybin therapy and have shown that psilocybin is at least as […]

Open source BibTeX RIS

Bibliographic context

Journal
Pharmaceutical journal/˜The œpharmaceutical journal
Date
2021-12-31
Source
OpenAlex
DOI
10.1211/pj.2022.1.169269
PubMed
Unavailable

Authors

Watch author

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Related papers